Publication Year

Yong M, Jensen AO, Jacobsen JB, Nørgaard M, Fryzek JP, Sørensen HT. The Incidence of Bone Metastases and Skeletal-Related Events in Breast Cancer Patients: A Population-Based Cohort Study in Denmark (1999 – 2007). 32nd Annual San Antonio Breast Cancer Symposium, San Antonio, TX. December 9-13, 2009.

Beebe-Dimmer JL, Cetin K, Fryzek JP, Schuetze SM, Schwartz K. 2009. The epidemiology of malignant giant cell tumors of bone: An analysis of data from the Surveillance, Epidemiology and End Results Program (1975-2004). Rare Tumors 1(2):e52.

Garabrant DH, Hong B, Jolliet O, Chen Q, Jiang X, Franzblau A, Lepkowski J, Adriaens P, Demond A, Hedgeman E, Knutson K, Towey T, Gillespie B. “UMDES results from the linear and logistic regression models. International Society for Exposure Science, Minneapolis, MN, November 1, 2009.

Yong M, Jensen AO, Jacobsen JB, Nørgaard M, Fryzek JP, Sørensen HT. The prognostic implications of bone metastases and skeletal-related events on breast cancer survival: A population-based cohort study in Denmark (1999-2007). American Society of Clinical Oncology Breast Cancer Symposium. San, Francisco, CA. October 8-10, 2009.

Langeberg W, O’Malley C, Critchlow C, Fryzek J. Prevalence of comorbidities at breast cancer diagnosis and subsequent risk of renal failure. American Society of Clinical Oncology Breast Cancer Symposium, San Francisco, CA. October 8-10, 2009.

Cohen SS, Signorello LB, Blot WJ. 2009. Adult weight gain and diabetes among African American and white adults in southeastern US communities. Prev Med 49(6):476-781.

Cohen SS, Gammon MD, Millikan RC, North KE, Lange EM, Signorello LB, Blot WJ, Matthews CE. Serum adiponectin in relation to body mass index and other behavioral and environmental predictors in African-American and white women.Obesity Society Annual Meeting, Washington, DC. October 1, 2009.

Thomsen RW, Schoonen WM, Farkas DK, Riis A, Jacobsen J, Fryzek JP, Sørensen HT. 2009. Risk for hospital contact with infection in patients with splenectomy: A population-based cohort study. Ann Intern Med 151(8):546-555.

Jiang X, Chen Q, Garabrant D, Hong B, Gillespie B, Lepkowski J, Franzblau A, Adriaens P, Demond A. Logistic Regression Models of High Serum Dioxin Level. Dioxin 2009 Conference, Beijing, China. August 27, 2009.

Cohen SS, Larson CO, Matthews CE, Buchowski MS, Signorello LB, Hargreaves MK, Blot WJ. 2009. Parity and breastfeeding in relation to obesity among black and white women in the southern community cohort study. J Womens Health (Larchmt) 18(9):1323-1332.

Hong B,Garabrant D, Jiang X, Chen Q, Franzblau A, Gillespie B, Lepkowski J, Adriaens P, Demond A.  Factors that Predict Serum Concentration of 2,3,7,8-TCDD in People from Michigan. USA Dioxin 2009 Conference, Beijing, China. August 27, 2009.

Gillespie B, Reichert H, Chen Q, Franzblau A, Lepkowski J, Adriaens P, Demond A, Luksemburg W, Garabrant D. Estimating population percentiles using the Turnbull estimator when some data are below the limit of detection. Dioxin 2009 Conference, Beijing, China. August 27, 2009.

Jensen AØ, Nørgaard M, Yong M, Fryzek JP, Sørensen HT. 2009. Validity of the recorded International Classification of Diseases, 10th edition diagnoses codes of bone metastases and skeletal-related events in breast and prostate cancer patients in the Danish National Registry of Patients. Clin Epidemiol 1:101-108.

Garabrant D, Hong B, Jolliet O, Chen Q, Jiang X, Franzblau A, Lepkowski J, Adriaens P, Demond A, Hedgeman E, Knutson K, Towey T, Gillespie B. Public Health Impact of Dioxin Exposure Pathways in the UMDES, Based on Linear Regression Models. Dioxin 2009 Conference, Beijing, China. August 27, 2009.

Signorello LB, Munro HM, Buchowski MS, Schlundt DG, Cohen SS, Hargreaves MK, Blot WJ. 2009. Estimating nutrient intake from a food frequency questionnaire: Incorporating the elements of race and geographic region. Am J Epidemiol 170(1):104-111.

Franzblau A, Hedgeman E, Jiang X, Chen Q, Hong B, Knutson K, Towey T, Adriaens P, Demond A, Gillespie B, Jolliet O, Lepkowski J, Garabrant D. The University of Michigan Dioxin Exposure Study: An Investigation of Serum Outliers for TEQ, 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, and PCB-126. Dioxin 2009 Conference, Beijing, China. August 27, 2009.

Evans M, Fored CM, Bellocco R, Fitzmaurice G, Fryzek JP, McLaughlin JK, Nyrén O, Elinder CG. 2009. Acetaminophen, aspirin and progression of advanced chronic kidney disease. Nephrol Dial Transplant 24(6):1908-1918.

Norgaard M, Jensen AO, Farkas DK, Pedersen L, Fryzek JP, Zhao S, Sorensen HT. Factors associated with Receipt of Splenectomy for Patients with Chronic Idiopathic Thrombocytopenic Purpura-A Nationwide Cohort Study. Pharmacoepidemiology and Drug Safety 18: S158-S159. August 1, 2009.

Franzblau A, Hedgeman E, Jiang X, Chen Q, Hong B, Knutson K, Towey T, Adriaens P, Demond A, Gillespie B, Jolliet O, Lepkowski J, Garabrant D. “The University of Michigan Dioxin Exposure Study: An investigation of serum outliers for TEQ, 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF and PCB-126. Dioxin 2009 Conference, Beijing, China. August 1, 2009.

Gatto N, Kelsh M, HaMai D, Suh M, Proctor D. A meta-analysis of the relationship between occupational exposure to hexavalent chromium and cancers of the gastrointestinal tract. Society of Toxicology 48th Annual Meeting, Baltimore, MD, March 2009.

Schoonon WM, Li L, Fryzek JP, Kaye JA. Medical Contraindictions for Splenectomy among Adults with Immune Thrombocytopenic Purpura: Data from the General Practice Research Database 14th Annual Meeting of the European-Hematology- Association, Berlin, Germany. June 4-7, 2009.

Schoonen WM, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, Fryzek J, Kaye JA. 2009. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol 145(2):235-244.

Cherkowski G, Dietrich J, Chen F, Fryzek J, Bridges K. Heparin use and venous thromboembolism (VTE) among cancer patients receiving chemotherapy with a prior history of VTE. American Society of Clinical Oncology Annual Conference, Orlando, FL.May 29 – June 2, 2009.

Fryzek JP, Cetin K, Nørgaard M, Jensen AO, Jacobsen JB, Sørensen HT. The prognostic significance of bone metastases and skeletal-related events (SREs) in prostate cancer survival: a population-based historical cohort study in Denmark (1999-2007) American Society of Clinical Oncology Annual Conference, Orlando, FL. May 29 – June 2, 2009.

Barlev A, Yong M, Cherkowski G, Cetin K, Fryzek JP. Prevalence of early-stage prostate and estrogen receptor positive breast cancer patients receiving primary androgen deprivation therapy and aromatase inhibitors in the United States. American Society of Clinical Oncology Annual Conference, Orlando, FL. May 29 – June 2, 2009.

Langeberg W, O’Malley C, Critchlow C, Fryzek J. Risk of acute renal failure among breast cancer patients and chemotherapy treatment of breast cancer patients with a history of renal insufficiency in a commercially-insured population in the United States. American Society of Clinical Oncology Annual Conference, Orlando, FL. May 29 – June 2, 2009.

Yong M, Jensen AO, Jacobsen JB, Nørgaard M, Fryzek JP, Sørensen HT. Survival associated with bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark (1999 – 2007) American Society of Clinical Oncology Annual Conference, Orlando, FL. May 29 – June 2, 2009.

Christiansen CF, Johansen MB, Christensen S, Langeberg W, Fryzek J, Sørensen HT. Incidence of Acute Kidney Injury in Cancer Patients: A Population-based Cohort Study in Denmark. American Society of Clinical Oncology Annual Conference, Orlando, FL. May 29 – June 2, 2009.

Schoonen W, Aagnes B, Bray F, Hansen S, Fryzek J, Weiderpass E. Incidence of Myelodysplastic syndromes (MDS) in the geographically defined area of South-Western Greece. 10th International Symposium on Myelodysplastic Syndromes, Patras, Greece. May 6-9, 2009.

Schoonen W, Asgnes B, Bray F, Hansen S, Fryzek J, Weiderpass E. Incidence of myelodysplastic syndromes (MDS) and Chronic Myelomonocytic leukemia (CMML) in Norway 1993-2006. 10th Symposium on Myelodysplastic Syndromes, Patras, Greece. May 6-9, 2009.

Taioli E, Du Y, Yong M, Fryzek J. Incidence of Myelodysplastic Syndrome in Western Pennsylvania 10th International Symposium on Myelodysplastic Syndromes, Patras, Greece. May 6-9, 2009.

Taioli E, Du Y, Fryzek J, Sekeres M. Literature review on the Epidemiology of Myelodysplastic Syndrome (MDS). 10th International Symposium on Myelodysplastic Syndromes. Patras, Greece. May 6-9, 2009.

Schoonen W, Strupp C, Aul C, Fryzek J, Germing U. Incidence and prevalence of Myelodysplastic Syndromes (MDS) in Duesseldorf 1996-2005, 10th Internationals Symposium on Myelodysplastic Syndromes, Patras, Greece. May 1, 2009.

Jiang X, Chen Q, Garabrant DH, Hong B, Gillespie B, Lepkowski J, Franzblau A, Adriaens P, Demond A. Logistic Regression Models of High Serum Dioxin Levels 30th International Symposium on Halogenated Persistent Organic Pollutants – Dioxin 2009. 2009.